Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8722513 | Digestive and Liver Disease | 2017 | 23 Pages |
Abstract
APRI and Fib-4 scores are reasonable tools to allocate NAFLD patients with advanced fibrosis. FIB-4 may better discriminate between intermediate fibrosis stages.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Noam Peleg, Assaf Issachar, Orly Sneh-Arbib, Amir Shlomai,